Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

473 ARTÍCULOS , VIENDO DEL 211 AL 225

Early morning off in patients with Parkinson's disease: a Chinese nationwide study and a 7-question screening scale

Han C, Mao W, An J, Jiao L, Chan P; China Early Morning Off (EMO) Study Group.

Transl Neurodegener. 2020 Jul 6;9(1):29. doi: 10.1186/s40035-020-00208-z.

Modeling Parkinson's Disease in Zebrafish

Najib NHM, Nies YH, Abd Halim SAS, Yahaya MF, Das S, Lim WL, Teoh SL.

CNS Neurol Disord Drug Targets. 2020;19(5):386-399. doi: 10.2174/1871527319666200708124117.

A Novel Mutation of PARK-2 Gene in a Patient with Early-onset Parkinson's Disease

Alafifi T, Bakhsh ARA, Elbashari M, Abouelnaga MEH, Eldimllawi AM.

Oman Med J. 2020 Jun 30;35(3):e140. doi: 10.5001/omj.2020.58. eCollection 2020 May.

Dopamine-responsive and dopamine-resistant resting tremor in Parkinson disease

Zach H, Dirkx MF, Roth D, Pasman JW, Bloem BR, Helmich RC.

Neurology. 2020 Sep 15;95(11):e1461-e1470. doi: 10.1212/WNL.0000000000010316. Epub 2020 Jul 10.

Tremor pathophysiology: lessons from neuroimaging

Madelein van der Stouwe AM, Nieuwhof F, Helmich RC.

Curr Opin Neurol. 2020 Aug;33(4):474-481. doi: 10.1097/WCO.0000000000000829.

Magnetic resonance-guided focused ultrasound for movement disorders: clinical and neuroimaging advances

Martínez-Fernández R, Pineda-Pardo JA.

Curr Opin Neurol. 2020 Aug;33(4):488-497. doi: 10.1097/WCO.0000000000000840.

Implementation of Mobile Health Technologies in Clinical Trials of Movement Disorders: Underutilized Potential

Artusi CA, Imbalzano G, Sturchio A, Pilotto A, Montanaro E, Padovani A, Lopiano L, Maetzler W, Espay AJ.

Neurotherapeutics. 2020 Oct;17(4):1736-1746. doi: 10.1007/s13311-020-00901-x.

Management of Visual Dysfunction in Patients with Parkinson's Disease

Savitt J, Aouchiche R.

J Parkinsons Dis. 2020;10(s1):S49-S56. doi: 10.3233/JPD-202103.

Therapy of Parkinson's Disease Subtypes

Marras C, Chaudhuri KR, Titova N, Mestre TA.

Neurotherapeutics. 2020 Oct;17(4):1366-1377. doi: 10.1007/s13311-020-00894-7.

Biofluid Markers for Prodromal Parkinson's Disease: Evidence From a Catecholaminergic Perspective

Vermeiren Y, Hirschberg Y, Mertens I, De Deyn PP.

Front Neurol. 2020 Jul 15;11:595. doi: 10.3389/fneur.2020.00595. eCollection 2020.

Effects of pedunculopontine nucleus deep brain stimulation on gait disorders in Parkinson's Disease: A meta-analysis of the literature

Yu K, Ren Z, Guo S, Li J, Li Y.

Clin Neurol Neurosurg. 2020 Nov;198:106108. doi: 10.1016/j.clineuro.2020.106108. Epub 2020 Jul 29.

Auditory and Olfactory Deficits in Essential Tremor - Review of the Current Evidence

Sengul Y.

Tremor Other Hyperkinet Mov (N Y). 2020 Jun 9;10:3. doi: 10.5334/tohm.57.

Deep Brain Stimulation Target Selection in Co-Morbid Essential Tremor and Parkinson's Disease

Wadhwa A, Schaefer S, Gerrard J, Deeb W, Okun MS, Patel A.

Tremor Other Hyperkinet Mov (N Y). 2020 Jul 8;10:17. doi: 10.5334/tohm.62.

Complementary Therapies in Parkinson Disease: a Review of Acupuncture, Tai Chi, Qi Gong, Yoga, and Cannabis

Deuel LM, Seeberger LC.

Neurotherapeutics. 2020 Oct;17(4):1434-1455. doi: 10.1007/s13311-020-00900-y.

Non-Dopaminergic Treatments for Motor Control in Parkinson's Disease: An Update

Gonzalez-Latapi P, Bhowmick SS, Saranza G, Fox SH.

CNS Drugs. 2020 Oct;34(10):1025-1044. doi: 10.1007/s40263-020-00754-0.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias